FN-1501 is primarily investigated for its potential in cancer treatment, particularly as an inhibitor of specific enzymes or pathways involved in tumor growth. It is being studied for its ability to target and disrupt the signaling mechanisms that allow cancer cells to proliferate and survive. Researchers are exploring its efficacy in various types of cancers, focusing on its role in enhancing the effectiveness of existing therapies or as a standalone treatment. Additionally, FN-1501 is being examined for its potential to reduce drug resistance in cancer cells, offering a promising avenue for improving patient outcomes in oncology.